Minoxidil

Manufacturer
Hi-Tech Pharmacal Co., Inc. | Akorn Operating Company LLC
Effective date
2020-10-05
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
legacy-cache
Hydrated at
2026-08-01 23:12:25

Label at a glance#

ProductMinoxidil
Active ingredientMINOXIDIL
Label structure10 sections

Indications and uses

to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)

Dosage and administration

• apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area • using more or more often will not improve results • continues use is necessary to increase and keep your hair regrowth, or hair loss will begin again

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Minoxidil 2% w/

Purpose

OTC - PURPOSE SECTION

Hair regrowth treatment

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

May be harmful if used when pregnant or breast-feeding.

If swallowed, get medical help or contact a Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)

Warnings

WARNINGS SECTION

For external use only

Flammable: Keep away from fire or flame

Do no use if

OTC - DO NOT USE SECTION

  • your amount of hair loss is different than that shown on the side of this carton or your hair loss is on the front of the scalp. Minoxidil topical solution 2% is not intended for frontal baldness or receding hairline.
  • you have no family history of hair loss
  • your hair loss is sudden and/or patchy
  • you do not know the reason for your hair loss
  • you are under 18 years of age. Do not use on babies and children.
  • your scalp is red, inflamed, infected, irritated, or painful
  • you use other medicines on the scalp

Ask a doctor before use if you have

SPL UNCLASSIFIED SECTION

heart disease

When using this product

SPL UNCLASSIFIED SECTION

  • do not apply on other parts of the body
  • avoid contact with the eyes. In case of accidental contact, rinse eyes with large amounts of cool tap water.
  • some people have experienced changes in hair color and/or texture
  • it takes time to regrow hair. You may need to use this product 2 times a day for at least 4 months before you see results.
  • the amount of hair regrowth is different for each person. This product will not work for everyone

Stop use and ask a doctor if

SPL UNCLASSIFIED SECTION

  • chest pain, rapid heartbeat, faintness, or dizziness occurs
  • sudden, unexplained weight gain occurs
  • your feet or hands swell
  • scalp irritation or redness occurs
  • unwanted facial hair growth occurs
  • you do not see hair regrowth in 4 months

Directions

DOSAGE & ADMINISTRATION SECTION

  • apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area
  • using more or more often will not improve results
  • continues use is necessary to increase and keep your hair regrowth, or hair loss will begin again

Other Information

SPL UNCLASSIFIED SECTION

  • see hair loss pictures on side of this carton
  • before use, read all information on carton and enclosed insert
  • keep the carton. It contains important information.
  • In clinical studies of mostly white men aged 18-49 years with moderate degrees of hair loss, the following response to minoxidil topical solution was reported: 26% of men reported moderate to dense hair regrowth after using minoxidil topical solution for 4 months (26% had moderate to dense regrowth; 33% had minimal regrowth). This compares with 11% of men reporting hair regrowth after using the placebo, the liquid without minoxidil in it, for 4 months (11% had moderate to dense regrowth; 31% had minimal regrowth).
  • store at controlled room temperature 20° to 25°C (68° to 77°F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

alcohol (60% v/v), propylene glycol, purified water

Questions or comments?

SPL UNCLASSIFIED SECTION

If you have any questions, ask your healthcare professional or call us at 1-800-262-9010.

PackageLabel Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton
Carton

NDC 50383-001-02

Minoxidil Topical Solution, USP 2%

Regular Strength Hair Regrowth Treatment

FOR MEN

Clinically Proven to Help Regrow Hair

Revitalizes Hair Follicles

One Month Supply

1-60 mL (2 fl. oz.) Bottle

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MINOXIDILACTIVE INGREDIENT5965120SH14
MINOXIDILACTIVE MOIETY5965120SH14
ALCOHOLINACTIVE INGREDIENT3K9958V90M4
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V34
WATERINACTIVE INGREDIENT059QF0KO0R4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50383-00150383-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 140 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALCOHOLALCOHOL3K9958V90MPASTE / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM / BUCCAL1.48 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TOPICAL3633 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / RESPIRATORY (INHALATION)10 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / RESPIRATORY (INHALATION)35.75 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TRANSDERMAL90 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / RECTAL1214 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / INTRAVENOUS99 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / RECTAL27 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / RECTAL3315 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / AURICULAR (OTIC)10 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MELIXIR / ORAL13675 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSHAMPOO / TOPICAL714 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL / TOPICAL19.2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / RECTAL0.35 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / TOPICAL5.28 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / SUBLINGUAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / NASAL70 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPONGE / TOPICAL40 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / DENTALNAExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY, METERED / SUBLINGUAL29 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, EMULSION / INTRAVENOUS520 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MMOUTHWASH / BUCCAL200 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3PASTE / DENTAL0.5 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET / ORAL64 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVASCULAR100 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYSTEM / TOPICAL4200 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / ORAL210 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TOPICAL2445 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LOTION / TOPICAL3392 mgExact identifier — unii candidate
81 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A074731-001MINOXIDIL (FOR MEN)MINOXIDIL2%SOLUTION / TOPICAL1996-12-24
A074731-002MINOXIDIL (FOR WOMEN)MINOXIDIL2%SOLUTION / TOPICAL2005-05-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24c2088c7a36db…
2026-10-15 13:18:302026-09A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11c2088c7a36db…
2026-09-14 22:38:342026-08A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-2484e616aacf4f…
2026-09-14 22:38:342026-08A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-1184e616aacf4f…
2026-08-18 06:07:402026-07A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24caaa826d4ba7…
2026-08-18 06:07:402026-07A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-2403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-242680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-245bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24d06236e962d9…
2024-10-29 15:01 UTC2024-10A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-2479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-24301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-241e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-248072bd15b7f6…
2024-05-31 18:47 UTC2024-05A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-245c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-245d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A074731-001MINOXIDIL (FOR MEN)2%SOLUTION / TOPICAL1996-12-244b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A074731-002MINOXIDIL (FOR WOMEN)2%SOLUTION / TOPICAL2005-05-114b0b4de00fa7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3bf4e467-d970-40a9-bf82-003f73d788081c548d51-6c30-4d82-a572-76f83f2d6a952022-05-31WarningsExact identifier
spl set id: 1c548d51-6c30-4d82-a572-76f83f2d6a95

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.